New research shows a common over-the-counter drug may have significant benefits for people with colon and rectal cancer.

Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new Karolinska ...

Researchers found that 160 milligrams of daily aspirin significantly lowered cancer recurrence risk for colorectal patients with PIK3 pathway alterations.

A groundbreaking Swedish study has demonstrated that taking aspirin daily can slash the likelihood of colorectal cancer returning by more than half in certain patients. The research revealed that ...

Key Takeaways Daily aspirin can cut in half the risk that colon cancer will come backRisk of recurrence was 55% lower in ...